OVERVIEW

In the last few years, there has been dramatic advancement in the diagnostic tools and treatment options available for neuromuscular disorders. While this is a welcome development, it may be challenging for neurologists taking care of patients with neuromuscular disorders to keep up to date with all of these advances. The purpose of the Penn Neuromuscular Symposium is to provide both a basic approach to patients with neuromuscular disorders and an update on novel therapeutic agents and future directions. The symposium will also enhance collaboration and knowledge exchange among neurologists and other healthcare professionals taking care of this unique patient population, which will hope will also facilitate referral to exciting clinical trials here at Penn.

TARGET AUDIENCE

Specialties - NEUROLOGY, PHYSICAL MEDICINE AND REHABILITATION - Neuromuscular Medicine

LEARNING OBJECTIVES

Upon conclusion of this educational activity, the participant will be better able to:

1. Provide appropriate care to the patient with neuromuscular weakness
2. Identify patterns and red flags in peripheral neuropathy
3. Describe the difference between axonal and demyelinating neuropathy
4. Learn how to perform specialized testing for neuromuscular junction disorders
5. Review the electrophysiological appearance of neurogenic vs myopathic units
6. Explain the utility of autonomic testing
7. Review challenging cases, discuss the differential diagnosis, appropriate testing and treatment
8. Review the role of antibody testing in neuromuscular disorders
9. Review benefits of genetic testing in patients with neuromuscular disorders
10. Review novel therapy for autoimmune neuromuscular disorders
11. Explain novel therapy for inherited neuromuscular disorders

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Penn Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.